BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 22658217)

  • 1. Bladder cancer patterns of pelvic failure: implications for adjuvant radiation therapy.
    Baumann BC; Guzzo TJ; He J; Vaughn DJ; Keefe SM; Vapiwala N; Deville C; Bekelman JE; Tucker K; Hwang WT; Malkowicz SB; Christodouleas JP
    Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):363-9. PubMed ID: 22658217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel risk stratification to predict local-regional failures in urothelial carcinoma of the bladder after radical cystectomy.
    Baumann BC; Guzzo TJ; He J; Keefe SM; Tucker K; Bekelman JE; Hwang WT; Vaughn DJ; Malkowicz SB; Christodouleas JP
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):81-8. PubMed ID: 22543204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
    Steven K; Poulsen AL
    J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occult pelvic lymph node involvement in bladder cancer: implications for definitive radiation.
    Goldsmith B; Baumann BC; He J; Tucker K; Bekelman J; Deville C; Vapiwala N; Vaughn D; Keefe SM; Guzzo T; Malkowicz SB; Christodouleas JP
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):603-10. PubMed ID: 24411628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study.
    Zehnder P; Studer UE; Skinner EC; Dorin RP; Cai J; Roth B; Miranda G; Birkhäuser F; Stein J; Burkhard FC; Daneshmand S; Thalmann GN; Gill IS; Skinner DG
    J Urol; 2011 Oct; 186(4):1261-8. PubMed ID: 21849183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
    Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP
    J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
    Dotan ZA; Kavanagh K; Yossepowitch O; Kaag M; Olgac S; Donat M; Herr HW
    J Urol; 2007 Dec; 178(6):2308-12; discussion 2313. PubMed ID: 17936804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stage specific lymph node metastasis mapping in radical cystectomy specimens.
    Vazina A; Dugi D; Shariat SF; Evans J; Link R; Lerner SP
    J Urol; 2004 May; 171(5):1830-4. PubMed ID: 15076287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of Failure After Radical Cystectomy for pT3-4 Bladder Cancer: Implications for Adjuvant Radiation Therapy.
    Reddy AV; Pariser JJ; Pearce SM; Weichselbaum RR; Smith ND; Steinberg GD; Liauw SL
    Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1031-9. PubMed ID: 27026309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
    Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
    J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome after radical cystectomy with limited or extended pelvic lymph node dissection.
    Dhar NB; Klein EA; Reuther AM; Thalmann GN; Madersbacher S; Studer UE
    J Urol; 2008 Mar; 179(3):873-8; discussion 878. PubMed ID: 18221953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presacral and retroperitoneal lymph node involvement in urothelial bladder cancer: results of a prospective mapping study.
    Miocinovic R; Gong MC; Ghoneim IA; Fergany AF; Hansel DE; Stephenson AJ
    J Urol; 2011 Oct; 186(4):1269-73. PubMed ID: 21849181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathologic nodal staging score for bladder cancer: a decision tool for adjuvant therapy after radical cystectomy.
    Shariat SF; Rink M; Ehdaie B; Xylinas E; Babjuk M; Merseburger AS; Svatek RS; Cha EK; Tagawa ST; Fajkovic H; Novara G; Karakiewicz PI; Trinh QD; Daneshmand S; Lotan Y; Kassouf W; Fritsche HM; Chun FK; Sonpavde G; Joual A; Scherr DS; Gonen M
    Eur Urol; 2013 Feb; 63(2):371-8. PubMed ID: 22727174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended versus limited lymph node dissection in radical cystectomy: impact on recurrence pattern and survival.
    Jensen JB; Ulhøi BP; Jensen KM
    Int J Urol; 2012 Jan; 19(1):39-47. PubMed ID: 22050425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stage-specific impact of pelvic lymph node dissection on survival in patients with non-metastatic bladder cancer treated with radical cystectomy.
    Abdollah F; Sun M; Schmitges J; Djahangirian O; Tian Z; Jeldres C; Perrotte P; Shariat SF; Montorsi F; Karakiewicz PI
    BJU Int; 2012 Apr; 109(8):1147-54. PubMed ID: 21883849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphovascular invasion and the presence of more than three tumors are associated with poor outcomes of muscle-invasive bladder cancer after bladder-conserving therapies.
    Zhang M; Tao R; Zhang C; Shen Z
    Urology; 2010 Oct; 76(4):902-7. PubMed ID: 20709377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy.
    Mills RD; Turner WH; Fleischmann A; Markwalder R; Thalmann GN; Studer UE
    J Urol; 2001 Jul; 166(1):19-23. PubMed ID: 11435814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of adjuvant chemotherapy in transitional cell carcinoma of the urinary bladder with lymph node involvement and/or lymphovascular invasion treated by radical cystectomy.
    Park J; Park S; Song C; Doo C; Cho YM; Ahn H; Kim CS
    Urology; 2007 Aug; 70(2):257-62. PubMed ID: 17826485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphadenectomy in bladder cancer: how high is "high enough"?
    Stein JP
    Urol Oncol; 2006; 24(4):349-55. PubMed ID: 16818190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laparoendoscopic single-site radical cystectomy and pelvic lymph node dissection: initial experience and 2-year follow-up.
    Kaouk JH; Goel RK; White MA; White WM; Autorino R; Haber GP; Campbell SC
    Urology; 2010 Oct; 76(4):857-61. PubMed ID: 20646750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.